federal_register: 2016-28442

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2016-28442 Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability Notice Under the Federal Food, Drug, and Cosmetic Act (the FD&C Act), the Food and Drug Administration (FDA or Agency) is required to report annually in the Federal Register on the status of postmarketing requirements (PMRs) and postmarketing commitments (PMCs) required of, or agreed upon by, holders of approved drug and biological products. This notice is the Agency's report on the status of the studies and clinical trials that applicants have agreed to, or are required to, conduct. A supplemental report containing additional information and analyses on the status of PMRs and PMCs is available on FDA's Web site.\1\ --------------------------------------------------------------------------- 2016-11-28 2016 11 https://www.federalregister.gov/documents/2016/11/28/2016-28442/report-on-the-performance-of-drug-and-biologics-firms-in-conducting-postmarketing-requirements-and https://www.govinfo.gov/content/pkg/FR-2016-11-28/pdf/2016-28442.pdf Health and Human Services Department; Food and Drug Administration 221,199 Under the Federal Food, Drug, and Cosmetic Act (the FD&C Act), the Food and Drug Administration (FDA or Agency) is required to report annually in the Federal Register on the status of postmarketing requirements (PMRs) and postmarketing commitments...  

Links from other tables